Evidence map›Paper›PMID 21461982›Full record

ReviewCurrent topics in microbiology and immunology2012

Mucosal vaccines for biodefense.

N J Mantis, L A Morici, C J Roy

Open access · greenAbstract readReview
In one paragraph

Review in Current topics in microbiology and immunology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Immunity to ricin: fundamental insights into toxin-antibody interactions.Current topics in microbiology and immunology · 2012
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

N J MantisDivision of Infectious Diseases, Wadsworth Center, NYDOH, 120 New Scotland Ave, Albany, NY 12208, USA. nmantis@wadsworth.org
L A Morici
C J Roy
Tulane University · USWadsworth Center · US

Funding

Viral Pathogenesis and TherapeuticsU54AI057158 · NIAID · WADSWORTH CENTER · PI LIPKIN, W. IAN · 2003 to 2014
$100.8M
ZCM:A NOVEL BROAD-SPECTRUM MICROBICIDE FOR SEXUALLY TRANSMITTED INFECTIONSP51RR000164 · NCRR · TULANE UNIVERSITY OF LOUISIANA · PI MARX, PRESTON A · 1985 to 2011
$100.1M
Continued Development of a Recombinant Vaccine (RivaxTM) against Ricin ToxinU01AI070624 · NIAID · SOLIGENIX, INC. · PI BREY, ROBERT N. · 2006 to 2008
$5.0M
Small molecule inhibitors of ricin and shiga toxinsU01AI075509 · NIAID · UNIVERSITY OF TEXAS AT AUSTIN · PI ROBERTUS, JON D · 2007 to 2011
$3.1M
Ricin toxin: Neutralizing antibodies and vaccine designR03AI097688 · NIAID · WADSWORTH CENTER · PI MANTIS, NICHOLAS J. · 2012 to 2013
$136k
NCRR NIH HHS P51 RR000164NIAID NIH HHS R03 AI097688NIAID NIH HHS U01 AI070624NIAID NIH HHS U01AI070624NIAID NIH HHS U01 AI075509NIAID NIH HHS U01AI075509NIAID NIH HHS U54 AI057158NIAID NIH HHS U54AI057158
6 · The paper itself

Abstract

Bioterrorism is the deliberate release of biological toxins, pathogenic viruses, bacteria, parasites, or other infectious agents into the public sphere with the objective of causing panic, illness, and/or death on a local, regional, or possibly national scale. The list of potential biological agents compiled by the Centers for Disease Control and Prevention is long and diverse. However, a trait common to virtually all the potential bioterrorism agents is the fact that they are likely to be disseminated by either aerosol or in food/water supplies with the intention of targeting the mucosal surfaces of the respiratory or gastrointestinal tracts, respectively. In some instances, inhalation or ingestion would mimic the natural route by which humans are exposed to these agents. In other instances, (e.g., the inhalation of a toxin is normally associated with food borne illness), it would represent an unnatural route of exposure. For most potential bioterrorism agents, the respiratory or gastrointestinal mucosa may simply serve as a route of entry by which they gain access to the systemic compartment where intoxication/replication occurs. For others, however, the respiratory or gastrointestinal mucosa is the primary tissue associated with pathogenesis, and therefore, the tissue for which countermeasures must be developed.

Indexed as

Infection ControlAnimalsBioterrorismHumansInfectionsMucous MembraneUnited StatesVaccinesVaccines

Identifiers

PMID21461982
PMCPMC7121805
OpenAlexW157286669

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.